Alerta De Seguridad para Endurant Stent Graft System

Según National Institute of Drugs and Food Surveillance (INVIMA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Colombia que fue producido por Medtronic Ireland || Medtronic Inc.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    R1703-83
  • Número del evento
    2008DM-0002693
  • Fecha
    2017-03-01
  • País del evento
  • Fuente del evento
    INVIMA
  • URL de la fuente del evento
  • Notas / Alertas
    Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
  • Notas adicionales en la data
  • Causa
    The manufacturer states that it has detected that the referenced devices may be more susceptible to presenting a variable permeability in the tissue that may be associated with the seizures observed in the initial implant procedure, during the implant procedure, this variation of the permeability may cause the surgeon to categorize a endophagetype iv (which normally resolves itself over time) as a type iii endoleak due to tissue breakage, since it may appear that the leak is localized rather than diffuse, leading to unnecessary secondary interventions, leading to the occurrence possible adverse events on the patient.

Device

  • Modelo / Serial
  • Descripción del producto
    The ENDURANT endoprosthesis system is designed to treat infrarenal abdominal aortic or aortic iliac aorticilies using an endovascular technique. Once placed within the ureurysm, the enduran stent offers an alternative permanent conduit for blood flow within the vascular system of the patient, since it excludes the aneurysmal sac from blood flow and pressure.
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NIDFSINVIMA